Features and outcome of no-reflow after percutaneous coronary intervention
- 1 April 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (12) , 778-782
- https://doi.org/10.1016/s0002-9149(99)80410-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Platelet and neutrophil imaging techniques in the investigation of the response to thrombolytic therapy and the no-reflow phenomenonAmerican Heart Journal, 1993
- Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosisAmerican Heart Journal, 1992
- Early and late angiographic findings of the “no-reflow” phenomenon following direct angioplasty as primary treatment for acute myocardial infarctionAmerican Heart Journal, 1992
- Reperfusion of hibernating myocardium: Contractile function, high-energy phosphate content, and myocyte injury after 3 hours of sublethal ischemia and 3 hours of reperfusion in the canine modelAmerican Heart Journal, 1992
- Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following ptcaCatheterization and Cardiovascular Diagnosis, 1991
- No-reflow phenomenon during percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1988
- Demonstration of the “no-reflow” phenomenon by digital coronary arteriographyThe American Journal of Cardiology, 1986
- Scintigraphic evidence of the “No reflow” phenomenon in human beings after coronary thrombolysisJournal of the American College of Cardiology, 1985
- The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion.Circulation, 1984
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974